BioCentury | Feb 6, 2020
Management Tracks

BioMarin CFO steps down; plus Atara, Epirium, Abalos, CytomX and more

...spend two decades as an oncology clinical trials consultant and serves on the board of NeoGenomics Inc....
BioCentury | Feb 16, 2019
Finance

Earnings on deck

...Earnings on deck Company Date Pre/post mkt 4Q18 EPS est 4Q17 EPS Expected chg NeoGenomics Inc. (NASDAQ:NEO...
BioCentury | Dec 13, 2018
Company News

Management tracks: Ambys, Foghorn

...as a venture partner. Flagship launched Foghorn in March with a $50 million capital commitment. NeoGenomics Inc....
BioCentury | Oct 26, 2018
Company News

NeoGenomics to acquire Genoptix

...from Novartis in 2017. Genoptix Inc., Carlsbad, Calif. NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Business: Diagnostic NeoGenomics Inc....
...Genoptix Inc. (Carlsbad, Calif.) for $125 million in cash plus $1 million in NeoGenomics stock. NeoGenomics...
...August, NeoGenomics raised $125 million in a follow-on (see "Neogenomics Raises $125M Follow-on" ). Shannon Lehnbeuter Genoptix Inc. NeoGenomics Inc....
BioCentury | Aug 17, 2018
Financial News

NeoGenomics raises $125M follow-on

...diagnostics. NeoGenomics was off $0.57 to $12.50 on Aug. 10. NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Jennie Walters NeoGenomics Inc....
BioCentury | Aug 10, 2018
Financial News

NeoGenomics raises $125M follow-on

...sequencing cancer profiling, and develops companion diagnostics. NeoGenomics was off $0.57 to $12.50 on Friday. Jennie Walters NeoGenomics Inc....
BioCentury | Mar 19, 2018
Company News

Management tracks: J&J, Alder, CVS

...Tulstrup as president and CEO. He was CEO of Vifor Pharma Ltd. (SIX:VIFN). Diagnostic company NeoGenomics Inc....
BioCentury | Mar 15, 2018
Tools & Techniques

Shared burden

...Kettering Cancer Center (A) MSK-IMPACT Assay profiling mutations in tumor tissue using a 468-gene panel NeoGenomics Inc....
BioCentury | Mar 17, 2017
Company News

Definiens, NeoGenomics deal

...technology, with NeoGenomics' immunohistochemistry assays to improve pathology interpretation, standardize readout and optimize biomarker threshold. NeoGenomics...
...for publication. Definiens AG , Munich, Germany NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Business: Diagnostic Chris Lieu Definiens AG NeoGenomics Inc....
BioCentury | Dec 30, 2016
Financial News

NeoGenomics completes debt financing

...the announcement, was equal to LIBOR plus 300 basis points. NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Alex Himes NeoGenomics Inc....
Items per page:
1 - 10 of 48
BioCentury | Feb 6, 2020
Management Tracks

BioMarin CFO steps down; plus Atara, Epirium, Abalos, CytomX and more

...spend two decades as an oncology clinical trials consultant and serves on the board of NeoGenomics Inc....
BioCentury | Feb 16, 2019
Finance

Earnings on deck

...Earnings on deck Company Date Pre/post mkt 4Q18 EPS est 4Q17 EPS Expected chg NeoGenomics Inc. (NASDAQ:NEO...
BioCentury | Dec 13, 2018
Company News

Management tracks: Ambys, Foghorn

...as a venture partner. Flagship launched Foghorn in March with a $50 million capital commitment. NeoGenomics Inc....
BioCentury | Oct 26, 2018
Company News

NeoGenomics to acquire Genoptix

...from Novartis in 2017. Genoptix Inc., Carlsbad, Calif. NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Business: Diagnostic NeoGenomics Inc....
...Genoptix Inc. (Carlsbad, Calif.) for $125 million in cash plus $1 million in NeoGenomics stock. NeoGenomics...
...August, NeoGenomics raised $125 million in a follow-on (see "Neogenomics Raises $125M Follow-on" ). Shannon Lehnbeuter Genoptix Inc. NeoGenomics Inc....
BioCentury | Aug 17, 2018
Financial News

NeoGenomics raises $125M follow-on

...diagnostics. NeoGenomics was off $0.57 to $12.50 on Aug. 10. NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Jennie Walters NeoGenomics Inc....
BioCentury | Aug 10, 2018
Financial News

NeoGenomics raises $125M follow-on

...sequencing cancer profiling, and develops companion diagnostics. NeoGenomics was off $0.57 to $12.50 on Friday. Jennie Walters NeoGenomics Inc....
BioCentury | Mar 19, 2018
Company News

Management tracks: J&J, Alder, CVS

...Tulstrup as president and CEO. He was CEO of Vifor Pharma Ltd. (SIX:VIFN). Diagnostic company NeoGenomics Inc....
BioCentury | Mar 15, 2018
Tools & Techniques

Shared burden

...Kettering Cancer Center (A) MSK-IMPACT Assay profiling mutations in tumor tissue using a 468-gene panel NeoGenomics Inc....
BioCentury | Mar 17, 2017
Company News

Definiens, NeoGenomics deal

...technology, with NeoGenomics' immunohistochemistry assays to improve pathology interpretation, standardize readout and optimize biomarker threshold. NeoGenomics...
...for publication. Definiens AG , Munich, Germany NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Business: Diagnostic Chris Lieu Definiens AG NeoGenomics Inc....
BioCentury | Dec 30, 2016
Financial News

NeoGenomics completes debt financing

...the announcement, was equal to LIBOR plus 300 basis points. NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Alex Himes NeoGenomics Inc....
Items per page:
1 - 10 of 48